Skip to main content

Table 2 Clinical and pathological data of treated patients

From: Safety and preliminary results of perioperative chemotherapy and hyperthermic intraperitoneal chemotherapy (HIPEC) for high-risk gastric cancer patients

Patient number

Age (years)

Gender

TNM staging

Re-staging

Morbidity

Pathology staging

Follow-up (months)

Status

1

56

F

T4 N+

SD

Postoperative fever

T2 N0 M0

28

Alive, without disease

2

62

M

T4 N+

PR

Intraabdominal abscess

T4a N2 M0

60

Alive, without disease

3

34

F

T4 N+

PR

 

T2 N0 M0

10

Death due to cancer

4

47

M

T4 N+

SD

Pancreatic leakage

T4a N3a M0

26

Death due to cancer

5

49

F

T4 N+

PR

 

T4a N3a M0

33

Alive, without disease

6

50

M

T4 N+

PR

Postoperative fever

T1N1M0

52

Alive, without disease

7

39

M

T4 N+

SD

 

T4a N3b M0

9

Death due to cancer

8

49

M

T4 N+

PR

 

T0 N0 M0

22

Alive, without disease

9

56

M

T4 N+

PR

Postoperative fever

T4aN3aM0

20

Alive, without disease

10

34

F

T3 N+

PR

 

T3N3aM0

24

Alive, without disease

  1. F, female; M, male.
  2. Pathology staging: T, tumor; N, node; M, metastasis.